Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
450
-
Total 13F shares, excl. options
-
44.8M
-
Shares change
-
+376K
-
Total reported value, excl. options
-
$9.37B
-
Value change
-
+$62.5M
-
Put/Call ratio
-
0.48
-
Number of buys
-
218
-
Number of sells
-
-219
-
Price
-
$209.38
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2022
533 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q3 2022.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 450 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.8M shares
of 44.8M outstanding shares and own 99.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.41M shares), BlackRock Inc. (4.33M shares), FMR LLC (2.98M shares), Avoro Capital Advisors LLC (2.93M shares), RENAISSANCE TECHNOLOGIES LLC (2.55M shares), STATE STREET CORP (1.6M shares), WELLINGTON MANAGEMENT GROUP LLP (1.36M shares), Avidity Partners Management LP (970K shares), JANUS HENDERSON GROUP PLC (825K shares), and Palo Alto Investors LP (634K shares).
This table shows the top 450 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.